Indore, September 2026: In a major leap for preventive healthcare in Madhya Pradesh, Sampurna Sodani Diagnostic Clinic has introduced a revolutionary Blood Biomarker Test for the early detection of Alzheimer’s disease. This cutting-edge diagnostic tool can identify Alzheimer’s-related brain changes up to 10 to 15 years before clinical symptoms like memory loss appear, offering patients a crucial window for early intervention.
Alzheimer’s disease is a leading cause of dementia worldwide, often diagnosed only when cognitive decline has already severely impacted a patient’s life. Until now, confirming Alzheimer’s pathology required either highly invasive Cerebrospinal Fluid (CSF) tests—which involve a painful spinal tap—or Amyloid PET scans. Not only are both these traditional diagnostic methods exceedingly costly and difficult to access, but Amyloid PET scan facilities for Alzheimer’s are currently not even available in Indore, forcing families to travel to distant metropolitan cities.
“This new blood-based test is a game-changer for the public. It replaces painful and inaccessible procedures with a simple, highly accurate, and minimally invasive alternative right here in Indore,” said a spokesperson for Sampurna Healthcare. “Early diagnosis empowers patients and families to make informed medical decisions, start treatments when they are most effective, and plan for the future with clarity.”
The advanced automated test evaluates two clinically significant biomarkers—pTau217 and Aẞ42—which are core indicators of Alzheimer’s pathology.
The Alzheimer’s Blood Biomarker Test is highly recommended for:
Individuals aged 50 years and above
People experiencing early memory-related concerns or cognitive decline
Individuals with a family history of Alzheimer’s disease or dementia
Patients advised by neurologists or physicians for cognitive assessments
The test, which requires a simple K2 EDTA Plasma sample, delivers highly reliable results within just 24 hours.
With over 34 years of excellence in diagnostics, Sampurna Healthcare continues its commitment to bringing next-generation diagnostic technologies to Central India, significantly improving patient care and preventive health outcomes.
Featured Article
